Nolato AB (publ) Total Assets

Latest as of June 2026: Skr10.04 Billion SEK ≈ $1.08 Billion USD

Nolato AB (publ) total assets. Based on the latest financial reports, Nolato AB (publ) (NOLA-B) holds total assets worth Skr10.04 Billion SEK (≈ $1.08 Billion USD) as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see market value of Nolato AB (publ) for the company's overall valuation and market capitalisation.

Total Assets of Nolato AB (publ) (2002–2025)

Total assets of Nolato AB (publ) from 2002 to 2025. This chart illustrates how Nolato AB (publ)'s total assets have evolved over time, based on quarterly financial data. See Nolato AB (publ) (NOLA-B) stock price for real-time trading data and today's change.

Nolato AB (publ) - Asset Composition Analysis

Nolato AB (publ) Total Assets Breakdown (December 2025)

Nolato AB (publ) total assets breakdown as of December 2025. Nolato AB (publ)'s total assets of Skr10.04 Billion consist of 40.1% current assets and 59.9% non-current assets.

Asset Category Amount (SEK) % of Total Assets
Cash & Equivalents Skr482.00 Million 5.2%
Accounts Receivable Skr1.60 Billion 17.2%
Inventory Skr1.09 Billion 11.7%
Property, Plant & Equipment Skr3.36 Billion 36.2%
Intangible Assets Skr162.00 Million 1.8%
Goodwill Skr2.01 Billion 21.7%

Asset Composition Trend (2002–2025)

This chart illustrates how Nolato AB (publ)'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Nolato AB (publ) (NOLA-B) liquidity to equity ratio to assess how much short-term liquidity the company maintains relative to its equity base.

Key Asset Composition Facts

  • Current vs. Non-Current Assets: Nolato AB (publ)'s current assets represent 40.1% of total assets in 2025, a decrease from 50.8% in 2002.
  • Cash Position: Cash and equivalents constituted 5.2% of total assets in 2025, down from 9.3% in 2002.
  • Tangible vs. Intangible: Intangible assets (including goodwill) make up 22.0% of total assets, an increase from 4.0% in 2002.
  • Asset Diversification: The largest asset category is property, plant & equipment at 36.2% of total assets.

Nolato AB (publ) Competitors by Total Assets

Key competitors of Nolato AB (publ) based on total assets are shown below.

Company Country Total Assets
Shenzhen New Industries Biomedical
SHE:300832
China CN¥9.58 Billion
GN Store Nord
CO:GN
Denmark Dkr29.23 Billion
Shanghai Aohua Photoelectricity Endoscope Co. Ltd. A
SHG:688212
China CN¥1.86 Billion
Polynovo Ltd
AU:PNV
Australia AU$123.37 Million
L&C Bio Co. Ltd
KQ:290650
Korea ₩497.94 Billion
VIROMED MEDICAL NA O.N.
XETRA:VME
Germany €13.91 Million
Affluent Medical SAS
PA:AFME
France €59.84 Million
DRGEM Corporation
KQ:263690
Korea ₩131.65 Billion

Nolato AB (publ) - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric Current 1 Year Ago 5 Years Ago
Current Ratio 1.57 1.99 1.52
Quick Ratio 1.11 1.42 1.12
Cash Ratio 0.00 0.26 0.47
Working Capital Skr1.51 Billion Skr1.84 Billion Skr1.56 Billion

Nolato AB (publ) - Advanced Valuation Insights

This section examines the relationship between Nolato AB (publ)'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio 2.51
Latest Market Cap to Assets Ratio 0.15
Asset Growth Rate (YoY) -4.2%
Total Assets Skr9.28 Billion
Market Capitalization $1.36 Billion USD

Valuation Analysis

Below Book Valuation: The market values Nolato AB (publ)'s assets below their book value (0.15x), which may indicate investor concerns about asset quality or future growth.

Slight Asset Contraction: Nolato AB (publ)'s assets decreased by 4.2% over the past year, which may reflect streamlining or optimization of resources.

Annual Total Assets for Nolato AB (publ) (2002–2025)

The table below shows the annual total assets of Nolato AB (publ) from 2002 to 2025.

Year Total Assets Change
2025-12-31 Skr9.28 Billion
≈ $998.89 Million
-4.19%
2024-12-31 Skr9.69 Billion
≈ $1.04 Billion
+4.17%
2023-12-31 Skr9.30 Billion
≈ $1.00 Billion
-7.07%
2022-12-31 Skr10.01 Billion
≈ $1.08 Billion
-0.48%
2021-12-31 Skr10.05 Billion
≈ $1.08 Billion
+15.79%
2020-12-31 Skr8.68 Billion
≈ $934.54 Million
+41.57%
2019-12-31 Skr6.13 Billion
≈ $660.12 Million
+18.97%
2018-12-31 Skr5.16 Billion
≈ $554.87 Million
+8.50%
2017-12-31 Skr4.75 Billion
≈ $511.39 Million
+21.10%
2016-12-31 Skr3.92 Billion
≈ $422.29 Million
+21.37%
2015-12-31 Skr3.23 Billion
≈ $347.92 Million
+10.95%
2014-12-31 Skr2.91 Billion
≈ $313.59 Million
+13.25%
2013-12-31 Skr2.57 Billion
≈ $276.90 Million
-2.32%
2012-12-31 Skr2.63 Billion
≈ $283.46 Million
+22.85%
2011-12-31 Skr2.14 Billion
≈ $230.73 Million
-8.77%
2010-12-31 Skr2.35 Billion
≈ $252.90 Million
+11.22%
2009-12-31 Skr2.11 Billion
≈ $227.39 Million
-0.61%
2008-12-31 Skr2.13 Billion
≈ $228.79 Million
+10.84%
2007-12-31 Skr1.92 Billion
≈ $206.41 Million
+11.25%
2006-12-31 Skr1.72 Billion
≈ $185.53 Million
+3.36%
2005-12-31 Skr1.67 Billion
≈ $179.50 Million
+4.38%
2004-12-31 Skr1.60 Billion
≈ $171.97 Million
-12.92%
2003-12-31 Skr1.83 Billion
≈ $197.48 Million
-3.17%
2002-12-31 Skr1.90 Billion
≈ $203.93 Million
--

About Nolato AB (publ)

ST:NOLA-B Sweden Medical Devices
Market Cap
$1.36 Billion
Skr12.60 Billion SEK
Market Cap Rank
#7330 Global
#119 in Sweden
Share Price
Skr52.10
Change (1 day)
-2.98%
52-Week Range
Skr46.25 - Skr62.80
All Time High
Skr109.65
About

Nolato AB (publ) develops, manufactures, and sells plastic, silicone, and thermoplastic elastomer products in Europe, Asia, North America, and internationally. It operates through the Medical Solutions and Engineered Solutions segments. The company offers catheter balloons; breathing bags; non-conductive sealing and damping silicone products; primary plastic packaging for medicines; and crimp and… Read more